No allelic association or interaction of three known functional polymorphisms with bipolar disorder in a northern Swedish isolated population

Psychiatric Genetics

Volumn 16, Issue 5, 2006, Pages 209-212

  Van Den Bogaert, Ann ^a   Sleegers, Kristel ^a   De Zutter, Sonia ^a   Heyrman, Lien ^a   Norrback, Karl Fredrik ^b   Adolfsson, Rolf ^b   Van Broeckhoven, Christine ^a   Del Favero, Jurgen ^a,c  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UMEÅ UNIVERSITY   (Sweden)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Association study; Bipolar disorder; Catechol O methyltransferase; Dopamine D3 receptor; Interaction study; Serotonin transporter

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE 3 RECEPTOR; GLYCINE; METHIONINE; SERINE; SEROTONIN; SEROTONIN TRANSPORTER; VALINE;

ADULT; ALLELE; ARTICLE; BIPOLAR DISORDER; CAUSAL ATTRIBUTION; CONTROLLED STUDY; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PRIORITY JOURNAL; RECEPTOR GENE; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; SWEDEN;

ADULT; ALLELES; BIPOLAR DISORDER; CATECHOL O-METHYLTRANSFERASE; FEMALE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, DOPAMINE D3; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SWEDEN;

EID: 33748745194     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ypg.0000218623.03752.e4     Document Type: Article

References (38)

1. American Psychiatry Association (1994). Diagnostic and statistical manual of mental disorders. 4th ed. Washington, District of Columbia: American Psychiatric Press.
2. Anguelova M, Benkelfat C, Turecki G (2003). A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. affective disorders. Mol Psychiatry 8:574-591.
3. Benedetti F, Serretti A, Colombo C, Lilli R, Lorenzi C, Smeraldi E (2003). Dopamine receptor D2 and D3 gene variants are not associated with the antidepressant effect of total sleep deprivation in bipolar depression. Psychiatry Res 118:241-247.
4. Biomed European Bipolar Collaborative Group (1997). No association between bipolar disorder and alleles at a functional polymorphism in the COMT gene. Br J Psychiatry 170:526-528.
5. Craddock N, Dave S, Greening J (2001). Association studies of bipolar disorder. Bipolar Disord 3:284-298.
6. Crocq MA, Mant R, Asherson P, Williams J, Hode Y, Mayerova A, et al. (1992). Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet 29:858-860.
7. Furlong RA, Ho L, Walsh C, Rubinsztein JS, Jain S, Paykel ES, et al. (1998). Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. Am J Med Genet 81:58-63.
8. Gomez-Casero E, Perez de Castro I, Saiz-Ruiz J, Llinares C, Fernandez-Piqueras J (1996). No association between particular DRD3 and DAT gene polymorphisms and manic-depressive illness in a Spanish sample. Psychiatr Genet 6:209-212.
9. Gutierrez B, Bertranpetit J, Guillamat R, Valles V, Arranz MJ, Kerwin R, et al. (1997). Association analysis of the catechol O-methyltransferase gene and bipolar affective disorder. Am J Psychiatry 154:113-115.
10. Heiden A, Schussler P, Itzlinger U, Leisch F, Scharfetter J, Gebhardt C, et al. (2000). Association studies of candidate genes in bipolar disorders. Neuropsychobiology 42 (Suppl 1):18-21.
11. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, et al. (1996). Allelic variation of human serotonin transporter gene expression. J Neurochem 66:2621-2624.
12. Kirov G, Jones I, McCandless F, Craddock N, Owen MJ (1999). Family-based association studies of bipolar disorder with candidate genes involved in dopamine neurotransmission: DBH, DAT1, COMT, DRD2, DRD3 and DRD5. Mol Psychiatry 4:558-565.
13. Kunugi H, Vallada HP, Hoda F, Kirov G, Gill M, Aitchison KJ, et al. (1997). No evidence for an association of affective disorders with high- or low-activity allele of catechol-O-methyltransferase gene. Biol Psychiatry 42:282-285.
14. Lachman HM, Morrow B, Shprintzen R, Veit S, Parsia SS, Faedda G, et al. (1996). Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. Am J Med Genet 67:468-472.
15. Lachman HM, Kelsoe J, Moreno L, Katz S, Papolos DF (1997). Lack of association of catechol-O-methyltransferase (COMT) functional polymorphism in bipolar affective disorder. Psychiatr Genet 7:13-17.
16. Lasky-Su JA, Faraone SV, Glatt SJ, Tsuang MT (2005). Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders. Am J Med Genet B Neuropsychiatr Genet 133:110-115.
17. Lecrubier Y, Sheehan DV, Weiller E, Amorim P, Bonora I, Sheehan KH, et al. (1997). The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry 12:224-231.
18. Lesch KP, Mossner R (1998). Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders? Biol Psychiatry 44:179-192.
19. Manki H, Kanba S, Muramatsu T, Higuchi S, Suzuki E, Matsushita S, et al. (1996). Dopamine D2, D3 and D4 receptor and transporter gene polymorphisms and mood disorders. J Affect Disord 40:7-13.
20. Massat I, Souery D, Del-Favero J, Van Gestel S, Serretti A, Macciardi F, et al. (2002). Positive association of dopamine D2 receptor polymorphism with bipolar affective disorder in a European Multicenter Association Study of affective disorders. Am J Med Genet 114:177-185.
21. Maxwell ME (1992). Manual for the family interview for genetic studies (FIGS). Clinical neurogenetics branch, intramural research program. Bethesda, Maryland: National Institute of Mental Health.
22. Mendlewicz J, Massat I, Souery D, Del-Favero J, Oruc L, Nothen MM, et al. (2004). Serotonin transporter 5HTTLPR polymorphism and affective disorders: no evidence of association in a large European multicenter study. Eur J Hum Genet 12:377-382.
23. Mynett-Johnson LA, Murphy VE, Claffey E, Shields DC, McKeon P (1998). Preliminary evidence of an association between bipolar disorder in females and the catechol-O-methyltransferase gene. Psychiatr Genet 8:221-225.
24. Nilsson LG, Bäckman L, Erngrund K, Nyberg L, Adolfsson R, Bucht G, et al. (1997). The Betula prospective cohort study: memory, health and aging. Aging Neuropsychol Cogn 4:1-32.
25. Nilsson LG, Adolfsson R, Backman L, de Frias CM, Molander B, Nyberg L (2004). Betula: a prospective cohort study on memory, health and aging. Aging Neuropsychol Cogn 11:134-148.
26. Nurnberger JI Jr, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, et al. (1994). Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 51:849-859; discussion 863-844.
27. Oruc L, Furac I, Croux C, Jakovljevic M, Kracun I, Folnegovic V, et al. (1996). Association study between bipolar disorder and candidate genes involved in dopamine-serotonin metabolism and GABAergic neurotransmission: a preliminary report. Psychiatr Genet 6:213-217.
28. Parsian A, Chakraverty S, Todd RD (1995). Possible association between the dopamine D3 receptor gene and bipolar affective disorder. Am J Med Genet 60:234-237.
29. Piccardi MP, Severino G, Bocchetta A, Palmas MA, Ruiu S, Del Zompo M (1997). No evidence of association between dopamine D3 receptor gene and bipolar affective disorder. Am J Med Genet 74:137-139.
30. Pritchard JK, Rosenberg NA (1999). Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 65:220-228.
31. Raymond M, Rousset F (1995). GENEPOP (version 1.2): population genetics software for exact tests and ecumenicism. J. Heredity 86:248-249.
32. Savoye C, Laurent C, Amadeo S, Gheysen F, Leboyer M, Lejeune J, et al. (1998). No association between dopamine D1, D2, and D3 receptor genes and manic-depressive illness. Biol Psychiatry 44:644-647.
33. Schloss P, Williams DC (1998). The serotonin transporter: a primary target for antidepressant drugs. J Psychopharmacol 12:115-121.
34. Serretti A, Lilli R, Lorenzi C, Lattuada E, Cusin C, Smeraldi E (2002). Serotonin transporter gene (5-HTTLPR) and major psychoses. Mol Psychiatry 7:95-99.
35. Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC (1990). Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347:146-151.
36. Souery D, Lipp O, Mahieu B, Mendelbaum K, De Martelaer V, Van Broeckhoven C, et al. (1996). Association study of bipolar disorder with candidate genes involved in catecholamine neurotransmission: DRD2, DRD3, DAT1, and TH genes. Am J Med Genet 67:551-555.
37. Vogel M, Pfeifer S, Schaub RT, Grabe HJ, Barnow S, Freyberger HJ, et al. (2004). Decreased levels of dopamine D3 receptor mRNA in schizophrenic and bipolar patients. Neuropsychobiology 50:305-310.
38. Wing J, Babor T, Brugha T (1991). SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Geneva, Switzerland: World Health Organization, Division of Mental Health.